IL, USA, 1987. Teaching Molecular Microbiology course and Microbiology Lab for graduate student of Zoology, Department of Microbiology, SU, Carbondale, IL, USA, 1987. 4
V. MEMBERSHIP IN PROFESSIONAL ASSOCIATIONS: Editorial Board of Clinical Reviews and Opinions, 2009-present National committee on leishmaniasis management, 2088-present Editorial Board of Iranian Journal of Arthropod-Borne Diseases, 2007-present The Vienna Vaccine Safety Initiative, Implementation Working Group, 2007-present Member of Research Council of Iran Molecular Medicine Network, since Jan 2005-present The Brighton Collaboration/allergy working group 2002-present Editorial board, Iranian Journal of Dermatology, 1998-present Board of consultants, Medical Journal of the Islamic Republic of Iran, 1997-2000 American Society for Microbiology 1988 - 1998 VI. ADDITIONAL PROFESSIONAL ACTIVITIES: International research reference group on Leishmaniasis and Human African Trypanosomiasis, and Chagas Disease, TDR/WHO, 2008-present WHO/TDR Member Product Development Team, Leishmaniasis Vaccine. 1998-2002 WHO/TDR Steering Committee on Leishmaniases (observer) 1997 National Committee on Leishmaniases 1994-1998 National Committee on Tuberculosis 1994-1995 VII. ORAL PRESENTATION AND ABSTRACT Oral presentations Treatment Trials and vaccine development trials. Immunopathogenesis and Novel Treatment Strategies of Cutaneous Leishmaniasis, 10-11, 2010, Erlangen, Germany First generation leishmaniasis Vaccines: a review of effcacy feld trials. Reunião de Pesquisa Aplicada em Doença Leishmanioses, 26 to 29 October 2010, Uberaba/Minas Gerais, Brazil First generation leishmaniasis Vaccines: a review of effcacy feld trials. Reunião de Pesquisa Aplicada em Doença Leishmanioses 26 to 29 October 2010, Uberaba/Minas Gerais, Brazil A brief history of leishmanization: Leishmania vaccine, achievements and failures, 7th World Congress on Vaccines, Immunization and Immunotherapy, Berlin, Germany, 26-28 May 2010 History of Vaccination for Leishmaniasis, International Symposium on Leishmaniasis Vaccines, Recife, Brazil, 9 – 11 March, 2009. Comparison of the efficacy of weekly intralesional injections of meglumine antimoniate with twice a week injections in the of acute anthroponotic cutaneous leishmaniasis treatment. 4 th World Congress on Leishmaniasis, Lucknow, India, 3-7 February 2009. 5
- Page 1 and 2: CURRICULUM VITAE Ali Khamesipour, P
- Page 3: Clinical Laboratory Supervisor, 11/
- Page 7 and 8: Terrasini, Sicily, Italy Comparison
- Page 9 and 10: Amman, Jordan April 15-16, 1996. In
- Page 11 and 12: Hadighi R., Mohebali M., Khamesipou
- Page 13 and 14: and vaccine delivery, 15-19 Dec., 2
- Page 15 and 16: Hejazi, S.H., Kalantari, M., Jalaye
- Page 17 and 18: Khamesipour A., Hejazi, H., Alimoha
- Page 19 and 20: 14. Nateghi Rostami M., Keshavarz H
- Page 21 and 22: presentation of immunization safety
- Page 23 and 24: assessor-blind controlled trial. Ar
- Page 25 and 26: non-healing cases of cutaneous leis
- Page 27 and 28: Student name: Amir Ahmad, Akhavan,
- Page 29 and 30: Diseases & Leprosy, Tehran Universi
Change language